Generation Financial Statements From 2010 to 2024

GBIO Stock  USD 1.37  0.05  3.79%   
Generation Bio financial statements provide useful quarterly and yearly information to potential Generation Bio Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Generation Bio financial statements helps investors assess Generation Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Generation Bio's valuation are summarized below:
Market Capitalization
88.2 M
Enterprise Value Revenue
5.103
Revenue
18.6 M
Earnings Share
(2.19)
Quarterly Revenue Growth
2.52
We have found one hundred twenty available fundamental trends for Generation Bio, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Generation Bio's regular fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 22nd of November 2024, Market Cap is likely to drop to about 249.5 M. In addition to that, Enterprise Value is likely to drop to about 237 M

Generation Bio Total Revenue

6.2 Million

Check Generation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Generation Bio's main balance sheet or income statement drivers, such as Net Interest Income of 12.5 M, Interest Income of 12.5 M or Depreciation And Amortization of 3.8 M, as well as many indicators such as Price To Sales Ratio of 19.69, Dividend Yield of 0.0 or PTB Ratio of 0.55. Generation financial statements analysis is a perfect complement when working with Generation Bio Valuation or Volatility modules.
  
Check out the analysis of Generation Bio Correlation against competitors.

Generation Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets302.1 M374.8 M174.5 M
Slightly volatile
Other Current Liabilities9.4 M16.5 M6.6 M
Slightly volatile
Total Current Liabilities41.9 M39.9 M13.3 M
Slightly volatile
Other Liabilities12.4 M17.2 M7.8 M
Slightly volatile
Property Plant And Equipment Net58.3 M95.7 M27.5 M
Slightly volatile
Accounts Payable1.7 M2.3 M1.6 M
Very volatile
Cash113.7 M66.4 M52.8 M
Slightly volatile
Non Current Assets Total63.4 M102.1 M30.8 M
Slightly volatile
Non Currrent Assets Other863.6 K698 K1.6 M
Slightly volatile
Other Assets4.7 MM3.5 M
Slightly volatile
Cash And Short Term Investments233 M264.4 M140.2 M
Slightly volatile
Net Receivables4.4 M4.1 M1.4 M
Slightly volatile
Common Stock Total Equity4.2 K6.9 K2.5 K
Slightly volatile
Common Stock Shares Outstanding49.9 M64.5 M32 M
Slightly volatile
Liabilities And Stockholders Equity302.1 M374.8 M174.5 M
Slightly volatile
Non Current Liabilities Total73 M131.7 M104.6 M
Slightly volatile
Capital Surpluse878.3 M836.4 M243.2 M
Slightly volatile
Other Current Assets275.5 K290 KM
Slightly volatile
Other Stockholder Equity434.4 M774.2 M189.9 M
Slightly volatile
Total Liabilities119.6 M171.6 M118.2 M
Pretty Stable
Property Plant And Equipment Gross121.1 M115.3 M24.7 M
Slightly volatile
Total Current Assets238.6 M272.6 M143.7 M
Slightly volatile
Capital Stock4.8 KK2.6 K
Slightly volatile
Net Working Capital219.4 M232.7 M131.9 M
Slightly volatile
Common Stock4.8 KK2.6 K
Slightly volatile
Property Plant Equipment21.6 M25.5 M12.1 M
Slightly volatile
Current Deferred Revenue7.5 M14.9 M4.1 M
Slightly volatile
Inventory4.6 M4.4 M1.4 M
Slightly volatile
Deferred Long Term Liabilities362.4 K499.1 K197.5 K
Slightly volatile
Short Term Debt7.5 M8.1 M3.6 M
Slightly volatile
Short and Long Term Debt Total95.5 M97.9 M83 M
Slightly volatile

Generation Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income12.5 M12 M3.5 M
Slightly volatile
Depreciation And Amortization3.8 M5.3 M1.8 M
Slightly volatile
Selling General Administrative31.7 M50.9 M18.6 M
Slightly volatile
Other Operating Expenses107.3 M144.5 M66.1 M
Slightly volatile
Research Development75.6 M93.6 M47.5 M
Slightly volatile
Total Operating Expenses107.3 M144.5 M66.1 M
Slightly volatile
Reconciled Depreciation3.8 M5.3 M1.8 M
Slightly volatile
Cost Of Revenue83.8 M79.8 M13 M
Slightly volatile
Selling And Marketing Expenses18.6 M21 M22.8 M
Slightly volatile

Generation Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation15.2 M24.3 M8.4 M
Slightly volatile
Begin Period Cash Flow106 M98.9 M49.5 M
Slightly volatile
Depreciation3.8 M5.3 M1.8 M
Slightly volatile
Capital Expenditures6.8 M7.4 M5.4 M
Slightly volatile
Issuance Of Capital Stock34.2 M36 M108.5 M
Very volatile
Total Cash From Financing Activities34 M35.8 M101.5 M
Very volatile
End Period Cash Flow118 M72.2 M55.8 M
Slightly volatile
Change To Netincome36.6 M34.8 M10.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio19.6920.728.1 K
Slightly volatile
Days Sales Outstanding2802957.9 K
Slightly volatile
Stock Based Compensation To Revenue4.54.7459.8487
Slightly volatile
Capex To Depreciation1.341.40556.4307
Slightly volatile
EV To Sales25.5126.85K
Slightly volatile
Days Of Inventory On Hand0.00.01.0E-4
Slightly volatile
Payables Turnover35.7234.02176.7244
Slightly volatile
Sales General And Administrative To Revenue9.419.9157
Slightly volatile
Average Inventory0.40.450.49
Slightly volatile
Research And Ddevelopement To Revenue12.6914.2715.5397
Slightly volatile
Capex To Revenue1.371.4450.8714
Slightly volatile
Cash Per Share3.914.09974.2429
Pretty Stable
Days Payables Outstanding10.1910.7284311
Slightly volatile
Income Quality0.780.41660.7543
Slightly volatile
Current Ratio10.616.830112.2702
Very volatile
Receivables Turnover1.351.280.5717
Slightly volatile
Graham Number11.6411.796811.5549
Slightly volatile
Debt To Equity0.01490.02260.0138
Slightly volatile
Capex Per Share0.210.11470.1732
Pretty Stable
Average Receivables1.8 MM2.2 M
Slightly volatile
Revenue Per Share0.08650.08240.0368
Slightly volatile
Interest Debt Per Share0.190.180.0594
Slightly volatile
Debt To Assets0.01140.01690.0109
Slightly volatile
Operating Cycle205231251
Slightly volatile
Days Of Payables Outstanding10.1910.7284311
Slightly volatile
Ebt Per Ebit1.070.91380.9713
Slightly volatile
Total Debt To Capitalization0.01460.0220.0136
Slightly volatile
Debt Equity Ratio0.01490.02260.0138
Slightly volatile
Quick Ratio10.616.830112.2702
Very volatile
Net Income Per E B T1.071.110.9932
Slightly volatile
Cash Ratio1.581.66473.0225
Slightly volatile
Cash Conversion Cycle197221241
Slightly volatile
Days Of Inventory Outstanding0.00.01.0E-4
Slightly volatile
Days Of Sales Outstanding2802957.9 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.281.14021.1408
Pretty Stable
Fixed Asset Turnover0.02790.05560.0268
Slightly volatile
Debt Ratio0.01140.01690.0109
Slightly volatile
Price Sales Ratio19.6920.728.1 K
Slightly volatile
Asset Turnover0.01490.01420.0064
Slightly volatile

Generation Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap249.5 M262.7 M495.2 M
Pretty Stable
Enterprise Value237 M249.5 M463.6 M
Pretty Stable

Generation Fundamental Market Drivers

Cash And Short Term Investments264.4 M

Generation Upcoming Events

22nd of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Generation Bio Financial Statements

Generation Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Generation Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue14.9 M7.5 M
Total Revenue5.9 M6.2 M
Cost Of Revenue79.8 M83.8 M
Stock Based Compensation To Revenue 4.74  4.50 
Sales General And Administrative To Revenue 9.90  9.41 
Research And Ddevelopement To Revenue 14.27  12.69 
Capex To Revenue 1.44  1.37 
Revenue Per Share 0.08  0.09 
Ebit Per Revenue(21.12)(22.18)

Pair Trading with Generation Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Generation Stock

  0.65A Agilent Technologies Earnings Call This WeekPairCorr
  0.83ME 23Andme HoldingPairCorr
  0.67VALN Valneva SE ADRPairCorr
  0.71JNJ Johnson Johnson Sell-off TrendPairCorr

Moving against Generation Stock

  0.49MDGL Madrigal PharmaceuticalsPairCorr
  0.41RNXT RenovoRxPairCorr
  0.36KZR Kezar Life SciencesPairCorr
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out the analysis of Generation Bio Correlation against competitors.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.19)
Revenue Per Share
0.28
Quarterly Revenue Growth
2.52
Return On Assets
(0.19)
Return On Equity
(0.86)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.